Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA522012Executive Chairman
Cynthia Wong Hu472006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA502011Chief Accounting Officer & Vice President-Finance
Zuie Chin Huang, MBA522013Independent Director
Yue Alexander Wu PhD, MBA532013Independent Director
Franklin Cary Salisbury, Jr.612014Independent Director
Rajesh C. Shrotriya, MD732014Independent Director
Quan Zhou, PhD592016Director
James E. Goldschmidt, PhD-2016Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,276,119 31,099,805 51.6% 79,545 0.1% 51.6%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 10,028,579 16.7%
He Xie Ai Qi Investment Management Beijing Co. Ltd. 8,498,765 14.1%
IDG Capital Partners Co., Ltd. 6,842,783 11.4%
Zhejiang Kanglaite Group Co. Ltd. 4,938,269 8.20%
Celgene Corp. 2,464,987 4.09%
Emerging Technology Partners LLC 2,312,677 3.84%
Wellington Shields Capital Management LLC 528,447 0.88%
Wellington Shields & Co. LLC 505,474 0.84%
Kleiner Perkins Caufield & Byers LLC 416,666 0.69%
Tak W. Mak, PhD 365,376 0.61%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC82
INCYTE CORPORATION38.91%28 429
QUINTILES IMS HOLDINGS..3.48%18 567
LONZA GROUP AG3.18%10 618
CELLTRION, INC.--.--%9 982
SEATTLE GENETICS, INC.22.17%9 187
ALKERMES PLC7.50%9 058
QIAGEN NV-1.16%6 655
UNITED THERAPEUTICS CO..-3.26%6 348
IONIS PHARMACEUTICALS ..-19.32%4 808
ALNYLAM PHARMACEUTICAL..39.10%4 482
ICON PLC7.34%4 373
ACADIA PHARMACEUTICALS..24.34%4 335
CHARLES RIVER LABORATO..17.38%4 233
PRA HEALTH SCIENCES IN..17.80%3 971
GALAPAGOS32.70%3 926
BIO-TECHNE CORP-2.79%3 732
NEKTAR THERAPEUTICS97.23%3 681
PAREXEL INTERNATIONAL ..-4.06%3 195
BB BIOTECH AG-0.82%3 051
IRONWOOD PHARMACEUTICA..16.09%2 589
Sector Biotechnology & Medical Research - NEC
EntreMed Inc : Connections
The UNLV Foundation
Emerging Technology Partners LLC
MithraGen, Inc.
Superdata Software Holdings Ltd.
Wuhan Kindstar Diagnostics Co., Ltd.
Beijing Genetron Biotechnology Co. Ltd.
Amnis Corp.
Human Longevity, Inc.
Intradigm Corp.
IDG Technology Venture Investment IV LLC
ImmunoVentis, Inc.
OriGene Technologies, Inc.
National Foundation for Cancer Research
Circle Internet Financial, Inc.
Allos Therapeutics, Inc.
American-Sino OB/GYN Hospital
IDG Technology Venture Investment, Inc.
CVie Therapeutics Co. Ltd.
IDG Capital Partners Co., Ltd.
Zenesis Ltd.
OMNI Pharmaceuticals (USA), Inc.
WUPIMA, Inc.
Smooth Prosper Ltd.
Creditease Holdings Cayman Ltd.
GenScript Corp.
MZ Investment Holdings Ltd.
KPCB China Fund II LP
IDG Technology Venture Investment III LLC
Crown Bioscience, Inc.
IDG Technology Venture Investments LP
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2017 People , Fundamentals and Ownership